First Heartland Consultants, Inc. Q2 2016 Filing

Filed August 12, 2016

Portfolio Value

$912.1M

Holdings

303

Report Date

Q2 2016

Filing Type

13F-HR

All Holdings (303 positions)

#	Stock	Shares	Value	% Portfolio
301	—CTI BIOPHARMA CORP	14,924	$5K	0.00%
302	—REXAHN PHARMACEUTICALS INC	21,500	$5K	0.00%
303	—NEURALSTEM INC	10,000	$3K	0.00%

PreviousPage 4 of 4